The goal of this clinical trial is to assess the efficacy of CBT-NC intervention to determine its impact on mental health and suicidality in children ages 6-17. The main aims are: Aim 1: Examine CBT-NC efficacy for improving nightmare distress and frequency in youth with chronic nightmares by comparing the treatment and waitlist group. Aim 2: Examine whether improvements in nightmares relate to fewer mental health problems for youth by determining by comparing the treatment and waitlist group.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Changes in reports on Sleep Journal
Timeframe: Participants complete this daily from consent to baseline assessment (Week 0), during treatment, and before post-assessments, up to 20 weeks. They also complete a weekly version for 4 weeks following post-assessments (Weeks 10-14).
Change in Nightmare Disorder Diagnoses from Structure Clinical Interview for Sleep Disorders in Children (SCISD-Kid)
Timeframe: Participants will be assessed at baseline (Week 0) and at post-assessments, up to 20 weeks.
Change on the Columbia Suicide Severity Rating Scale (C-SSRS)
Timeframe: Participants will be assessed at baseline (Week 0), at post-assessments, up to 20 weeks, and weekly following their post-assessment for 4 weeks.
Change on the Strengths and Difficulties Questionnaire (SDQ) - Caregiver Version
Timeframe: Participants' caregivers will be assessed at baseline (Week 0) and at post-assessments, up to 20 weeks.
Change on the Patient Health-Questionnaire-9 (PHQ-9)
Timeframe: Participants will be assessed at baseline (Week 0) and at post-assessments, up to 20 weeks.